Needle-Free Injection Systems Market Competitive Landscape, Changing Market Trends & Emerging Opportunities
The global needle-free
injection systems market will experience extensive growth in the coming
years due to the rising demand for self-injection devices and emerging
biological therapies. The vendors of these systems offer fillable and prefilled
needle-free injectors in the market, of which prefilled needle-free injectors
constitute the larger share. The increasing demand for low-cost self-injection
devices by patients and healthcare providers and rising focus on compliance
with needle safety regulations to avoid needlestick injuries are some of the
factors that have led to an increase in the use of prefilled needle-free
injectors.
Needle-free
injection systems are generally penetrated via intramuscular, subcutaneous, and
intradermal routes. These injectors find their application in oncology, insulin
delivery, vaccine delivery, pain management, and others. Needle-free injectors
finds largest application in vaccine delivery, mainly because of the increasing
prevalence of chronic diseases. Insulin delivery application has also witnessed
significant growth with the use of needle-free injection systems by the
increasing patient base suffering from diabetes.
Request
to Get the Sample Pages at:
The
increasing demand and penetration of needle-free injection systems in emerging
economies offer enormous growth opportunities to the players in the needle-free
injection systems industry. Since needle-free injection systems make the whole
process of self-administration of drugs quite easy and convenient for the
patients, transition from hospital care to home care settings has been seen in
recent years. The shifting interest of consumers from hospital to home for
their healthcare needs has been a key trend observed in the needle-free
injection systems market.
Some of the
key players in the needle-free injection systems industry include Endo
International PLC, Antares Pharma Inc., Medical International Technology Inc.,
PharmaJet, Bioject Medical Technologies Inc., National Medical Products Inc.,
INJEX Pharma AG, Valeritas Holdings Inc., Crossject SA, PenJet Corporation, and
European Pharma Group.
In March
2017, PharmaJet announced its partnership with Serum Institute of India to
commercialize needle-free delivery of the measles, mumps, and rubella (MMR)
vaccine using the Stratis 0.5 mL needle-free injection system.
Comments
Post a Comment